Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer

Citation
K. Katano et al., Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer, ONCOL REP, 8(3), 2001, pp. 605-609
Citations number
21
Categorie Soggetti
Oncology
Journal title
ONCOLOGY REPORTS
ISSN journal
1021335X → ACNP
Volume
8
Issue
3
Year of publication
2001
Pages
605 - 609
Database
ISI
SICI code
1021-335X(200105/06)8:3<605:POIICC>2.0.ZU;2-X
Abstract
Intraoperative intrapleural (i.pl.) cisplatin (CDDP) treatment during thora cotomy was performed for esophageal cancers. Three patients underwent isoto nic (308 mOsm/1) CDDP treatment. Hypotonic CDDP treatments with a 154 mOsm/ 1 solution and a 62 mOsm/1 solution were administered to 4 and 9 patients, respectively. The maximum concentrations (C-max) of both total and filterab le platinum in the plasma after injection of the hypotonic solution were si gnificantly higher than those after injection of the isotonic solution. The area under the curve of concentration versus time (AUC) of the plasma of t he 62 mOsm/1 solution was significantly higher than that of the 154 mOsm/1 and isotonic solution. Although higher levels of the C-max may increase sid e-effects, the hypotonic condition of the i.pl. fluid and increased AUC in the plasma may escalate the accumulation of platinum in i.pl. cancer cells. These results suggest that hypotonic i.pl. CDDP is tolerable and may be us eful for treatment of the incipient phase of pleural carcinomatosis and for prophylaxis of postoperative recurrence.